Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
PAX Quote, Financials, Valuation and Earnings
Last price:
$13.90
Seasonality move
:
-3.29%
Day range:
$13.41 - $13.98
52-week range:
$9.43 - $14.52
Dividend yield:
5.4%
P/E ratio:
29.95x
P/S ratio:
5.56x
P/B ratio:
3.99x
Volume:
487.6K
Avg. volume:
529.1K
1-year change:
7.76%
Market cap:
$2.2B
Revenue:
$374.2M
EPS (TTM):
$0.46
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $115M | $235.5M | $258.9M | $327.6M | $374.2M | |
| Revenue Growth (YoY) | -6.86% | 104.77% | 9.92% | 26.55% | 14.22% | |
| Cost of Revenues | $10.6M | $14.6M | $34.8M | $38.7M | $50.5M | |
| Gross Profit | $104.4M | $220.9M | $224.1M | $288.9M | $323.7M | |
| Gross Profit Margin | 90.76% | 93.79% | 86.55% | 88.18% | 86.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $29.3M | $74.6M | $71.8M | $97.1M | $120.9M | |
| Other Inc / (Exp) | -$1.3M | -$14.3M | -$25.4M | -$43.4M | -$66.7M | |
| Operating Expenses | $37.2M | $83.7M | $93.6M | $125M | $157.8M | |
| Operating Income | $67.2M | $137.2M | $130.4M | $163.9M | $165.9M | |
| Net Interest Expenses | $968K | $1.4M | $2.6M | $2.4M | $13.2M | |
| EBT. Incl. Unusual Items | $65M | $121.6M | $102.5M | $118M | $86M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.1M | $381K | $8.3M | -$2.8M | $10.3M | |
| Net Income to Company | $61.8M | $121.2M | $94.1M | $120.8M | $75.7M | |
| Minority Interest in Earnings | $369K | $1.3M | -$1.1M | -$2.4M | -$3.8M | |
| Net Income to Common Excl Extra Items | $62.2M | $122.5M | $93M | $118.4M | $71.9M | |
| Basic EPS (Cont. Ops) | $0.53 | $0.90 | $0.63 | $0.80 | $0.47 | |
| Diluted EPS (Cont. Ops) | $0.53 | $0.90 | $0.63 | $0.80 | $0.47 | |
| Weighted Average Basic Share | $117M | $136M | $147.2M | $148.2M | $153.3M | |
| Weighted Average Diluted Share | $117M | $136M | $147.2M | $148.7M | $153.9M | |
| EBITDA | $73.5M | $131.4M | $125.5M | $146.4M | $133.2M | |
| EBIT | $65.8M | $122.6M | $104.3M | $119.2M | $97.4M | |
| Revenue (Reported) | $115M | $235.5M | $258.9M | $327.6M | $374.2M | |
| Operating Income (Reported) | $67.2M | $137.2M | $130.4M | $163.9M | $165.9M | |
| Operating Income (Adjusted) | $65.8M | $122.6M | $104.3M | $119.2M | $97.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.6M | $55M | $73.8M | $63.8M | $79.7M | |
| Revenue Growth (YoY) | 19.98% | 79.62% | 34.12% | -13.49% | 24.92% | |
| Cost of Revenues | $12M | $8.2M | $9.8M | $18.4M | $27.1M | |
| Gross Profit | $18.6M | $46.8M | $63.9M | $45.4M | $52.6M | |
| Gross Profit Margin | 60.75% | 85.1% | 86.7% | 71.16% | 66% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9M | $15.2M | $21.2M | $9.2M | $12M | |
| Other Inc / (Exp) | -$2.3M | -$3.1M | -$15.3M | -$9.6M | -$2.4M | |
| Operating Expenses | $2.4M | $20.7M | $27.4M | $15.3M | $21M | |
| Operating Income | $16.2M | $26.1M | $36.6M | $30.1M | $31.6M | |
| Net Interest Expenses | $287K | $481K | $562K | $600K | $7M | |
| EBT. Incl. Unusual Items | $13.6M | $22.5M | $20.7M | $20M | $22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $525K | $4.2M | $3.1M | $4.2M | $7.5M | |
| Net Income to Company | $13.1M | $18.3M | $17.6M | $15.9M | -- | |
| Minority Interest in Earnings | $1.3M | -- | -$316K | -$400K | -$900K | |
| Net Income to Common Excl Extra Items | $14.3M | $18.3M | $17.2M | $15.4M | $13.6M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.12 | $0.12 | $0.10 | $0.09 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.12 | $0.12 | $0.10 | $0.09 | |
| Weighted Average Basic Share | $136.1M | $147.2M | $147.5M | $150.7M | $158.1M | |
| Weighted Average Diluted Share | $136.1M | $147.2M | $147.6M | $150.7M | $158.1M | |
| EBITDA | $15.8M | $28M | $27M | $37.3M | $40.6M | |
| EBIT | $13.8M | $22.8M | $21M | $30.1M | $31.6M | |
| Revenue (Reported) | $30.6M | $55M | $73.8M | $63.8M | $79.7M | |
| Operating Income (Reported) | $16.2M | $26.1M | $36.6M | $30.1M | $31.6M | |
| Operating Income (Adjusted) | $13.8M | $22.8M | $21M | $30.1M | $31.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $120.1M | $259.9M | $277.6M | $317.7M | $390M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $14.1M | $10.8M | $36.5M | $47.3M | $66.8M | |
| Gross Profit | $106M | $249.1M | $241.1M | $270.3M | $323.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $29M | $87.8M | $77.8M | $85.1M | $117.4M | |
| Other Inc / (Exp) | -$4.5M | -$15M | -$37.6M | -$37.7M | -$59.5M | |
| Operating Expenses | $36.9M | $102M | $100.3M | $112.9M | $155.9M | |
| Operating Income | $69.1M | $147.1M | $140.8M | $157.4M | $167.3M | |
| Net Interest Expenses | $1M | $1.6M | $2.6M | $2.5M | $19.6M | |
| EBT. Incl. Unusual Items | $63.6M | $130.5M | $100.6M | $117.3M | $87.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1M | $4.1M | $7.3M | -$1.7M | $13.6M | |
| Net Income to Company | $62.5M | $126.4M | $93.3M | $119.1M | -- | |
| Minority Interest in Earnings | $1.9M | $1K | -$1.5M | -$2.5M | -$4.3M | |
| Net Income to Common Excl Extra Items | $64.4M | $126.4M | $91.9M | $116.6M | $70M | |
| Basic EPS (Cont. Ops) | $0.48 | $0.91 | $0.62 | $0.78 | $0.46 | |
| Diluted EPS (Cont. Ops) | $0.48 | $0.91 | $0.62 | $0.78 | $0.46 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $76.5M | $148M | $124.5M | $156.7M | $145.7M | |
| EBIT | $64.4M | $131.6M | $102.4M | $128.3M | $108.1M | |
| Revenue (Reported) | $120.1M | $259.9M | $277.6M | $317.7M | $390M | |
| Operating Income (Reported) | $69.1M | $147.1M | $140.8M | $157.4M | $167.3M | |
| Operating Income (Adjusted) | $64.4M | $131.6M | $102.4M | $128.3M | $108.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.6M | $55M | $73.8M | $63.8M | $79.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12M | $8.2M | $9.8M | $18.4M | $27.1M | |
| Gross Profit | $18.6M | $46.8M | $63.9M | $45.4M | $52.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9M | $15.2M | $21.2M | $9.2M | $12M | |
| Other Inc / (Exp) | -$2.3M | -$3.1M | -$15.3M | -$9.6M | -$2.4M | |
| Operating Expenses | $2.4M | $20.7M | $27.4M | $15.3M | $21M | |
| Operating Income | $16.2M | $26.1M | $36.6M | $30.1M | $31.6M | |
| Net Interest Expenses | $287K | $481K | $562K | $600K | $7M | |
| EBT. Incl. Unusual Items | $13.6M | $22.5M | $20.7M | $20M | $22M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $525K | $4.2M | $3.1M | $4.2M | $7.5M | |
| Net Income to Company | $13.1M | $18.3M | $17.6M | $15.9M | -- | |
| Minority Interest in Earnings | $1.3M | -- | -$316K | -$400K | -$900K | |
| Net Income to Common Excl Extra Items | $14.3M | $18.3M | $17.2M | $15.4M | $13.6M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.12 | $0.12 | $0.10 | $0.09 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.12 | $0.12 | $0.10 | $0.09 | |
| Weighted Average Basic Share | $136.1M | $147.2M | $147.5M | $150.7M | $158.1M | |
| Weighted Average Diluted Share | $136.1M | $147.2M | $147.6M | $150.7M | $158.1M | |
| EBITDA | $15.8M | $28M | $27M | $37.3M | $40.6M | |
| EBIT | $13.8M | $22.8M | $21M | $30.1M | $31.6M | |
| Revenue (Reported) | $30.6M | $55M | $73.8M | $63.8M | $79.7M | |
| Operating Income (Reported) | $16.2M | $26.1M | $36.6M | $30.1M | $31.6M | |
| Operating Income (Adjusted) | $13.8M | $22.8M | $21M | $30.1M | $31.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $14.1M | $15.3M | $26.5M | $16.1M | $33.4M | |
| Short Term Investments | $9.9M | $151.9M | $45.5M | $17.2M | $5M | |
| Accounts Receivable, Net | $24M | $97.1M | $125.4M | $127.4M | $217.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $4.1M | $6.4M | $12.1M | $27M | $20.4M | |
| Other Current Assets | $871K | $338K | $462K | $2.4M | $1.9M | |
| Total Current Assets | $53.7M | $352.3M | $479.6M | $401.6M | $372.7M | |
| Property Plant And Equipment | $4M | $16.5M | $26.4M | $30.2M | $34.9M | |
| Long-Term Investments | $2M | $18.3M | $43.2M | $58.6M | $50M | |
| Goodwill | -- | $242.9M | $276.8M | $311.2M | $356M | |
| Other Intangibles | $22.4M | $116M | $134.7M | $175.8M | $344.9M | |
| Other Long-Term Assets | -- | -- | $71K | $1.5M | $4.2M | |
| Total Assets | $107.2M | $761.3M | $976.2M | $1B | $1.2B | |
| Accounts Payable | $3M | $7.2M | $3.3M | $4.8M | $41.8M | |
| Accrued Expenses | -- | $11.6M | $10.4M | $9.4M | $31.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $78.5M | |
| Current Portion Of Capital Lease Obligations | $780K | $951K | $2.2M | $3M | $3.7M | |
| Other Current Liabilities | $1.4M | $217K | $235.3M | $269.5M | $75.8M | |
| Total Current Liabilities | $44M | $156.2M | $338M | $397.5M | $397.4M | |
| Long-Term Debt | -- | -- | -- | -- | $149.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $48.1M | $197M | $462.8M | $490.2M | $715.2M | |
| Common Stock | $1K | $15K | $15K | $15K | $15K | |
| Other Common Equity Adj | -- | $764K | $1.5M | $3M | $22M | |
| Common Equity | $57.3M | $564.3M | $552.8M | $542.5M | $481.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $1.8M | -- | -$39.3M | -$21.1M | $9.9M | |
| Total Equity | $59.1M | $564.3M | $513.5M | $521.3M | $490.9M | |
| Total Liabilities and Equity | $107.2M | $761.3M | $976.2M | $1B | $1.2B | |
| Cash and Short Terms | $24M | $167.1M | $72.1M | $33.2M | $38.4M | |
| Total Debt | -- | -- | -- | -- | $228M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $28.7M | $12.9M | $30.8M | $27M | $34.5M | |
| Short Term Investments | $300.4M | $136M | $10.5M | $6.9M | $140.9M | |
| Accounts Receivable, Net | $22.8M | $94M | $138.4M | $124.2M | $152.1M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $2.4M | $8.5M | $13.4M | $25.6M | $9.1M | |
| Other Current Assets | $296K | $58K | $342K | $5.5M | $17.9M | |
| Total Current Assets | $355.5M | $338.2M | $462.3M | $401M | $382.7M | |
| Property Plant And Equipment | $4.3M | $19.7M | $27.1M | $30.4M | $34.9M | |
| Long-Term Investments | $8M | $34.3M | $62.7M | $52.6M | $93.6M | |
| Goodwill | -- | $249.6M | $287.8M | $303.9M | -- | |
| Other Intangibles | $21.4M | $116.7M | $134.8M | $169.6M | -- | |
| Other Long-Term Assets | -- | $236.9M | $286K | $608K | $7M | |
| Total Assets | $413.5M | $1B | $999.8M | $1.1B | $1.3B | |
| Accounts Payable | $4.5M | $4.2M | $5.1M | $6.8M | -- | |
| Accrued Expenses | -- | $9.1M | $10.5M | $9.3M | $32M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $10.5M | $41.1M | |
| Current Portion Of Capital Lease Obligations | $933K | $1.5M | $2.6M | $3.2M | -- | |
| Other Current Liabilities | $1.4M | $254K | $242.3M | $273.6M | $218.7M | |
| Total Current Liabilities | $39.5M | $166.2M | $365.4M | $405.4M | $395.3M | |
| Long-Term Debt | -- | -- | -- | $73.4M | $151M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $43.6M | $435.3M | $505.4M | $555.6M | $718.1M | |
| Common Stock | $14K | $15K | $15K | $15K | -- | |
| Other Common Equity Adj | -- | $964K | $1.8M | $3.4M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -$394K | -- | -$44.8M | -$16.6M | $11.6M | |
| Total Equity | $369.9M | $573.4M | $494.4M | $498.3M | $561M | |
| Total Liabilities and Equity | $413.5M | $1B | $999.8M | $1.1B | $1.3B | |
| Cash and Short Terms | $329.1M | $148.9M | $41.3M | $33.9M | $175.4M | |
| Total Debt | -- | -- | -- | $83.8M | $192.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $61.8M | $121.2M | $94.1M | $120.8M | $75.7M | |
| Depreciation & Amoritzation | $7.7M | $8.8M | $21.2M | $27.1M | $35.8M | |
| Stock-Based Compensation | -- | $764K | $731K | $1.5M | $19.1M | |
| Change in Accounts Receivable | -$22.9M | -$65.3M | -$25.5M | -$10.7M | -$92.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $52.7M | $107.6M | $81.1M | $156.7M | $145.9M | |
| Capital Expenditures | $660K | $1.8M | $6.7M | $15M | $8.3M | |
| Cash Acquisitions | -- | -$122.8M | -$42.5M | -$7.2M | -$112.6M | |
| Cash From Investing | $23.5M | -$284.2M | -$189.3M | $62.2M | $25.3M | |
| Dividends Paid (Ex Special Dividend) | -$64.5M | -$119.8M | -$103.3M | -$145.1M | -$132.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $25M | $261M | |
| Long-Term Debt Repaid | -$893K | -$832K | -$1.7M | -$28.4M | -$48.4M | |
| Repurchase of Common Stock | -- | -- | -- | -$65.2M | -$141.3M | |
| Other Financing Activities | -- | -$3.2M | -$4.7M | -$14.7M | -$89.2M | |
| Cash From Financing | -$66.2M | $177.9M | $118.5M | -$229.6M | -$151.7M | |
| Beginning Cash (CF) | $4.1M | $14.1M | $15.3M | $26.5M | $16.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10M | $1.2M | $10.3M | -$10.7M | $19.6M | |
| Ending Cash (CF) | $14.1M | $15.3M | $26.5M | $16.1M | $33.4M | |
| Levered Free Cash Flow | $52M | $105.7M | $74.3M | $141.7M | $137.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.3M | $13.2M | $46.7M | $48.4M | $55.4M | |
| Depreciation & Amoritzation | $1.9M | $2.9M | $5.7M | $7.2M | $12.1M | |
| Stock-Based Compensation | -- | $65K | $215K | $491K | $6.4M | |
| Change in Accounts Receivable | -$8.3M | $30.7M | -$35.9M | $1.6M | -$131.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.6M | $28M | -$9.3M | $39.4M | $25.9M | |
| Capital Expenditures | -$1.2M | $784K | -$2.7M | $6.9M | $2.9M | |
| Cash Acquisitions | -- | -$122.8M | -$8.1M | -$5.3M | -$130K | |
| Cash From Investing | $6.5M | -$35.9M | $34.4M | -$8.6M | $2.1M | |
| Dividends Paid (Ex Special Dividend) | -$25M | -$19.1M | -$25.2M | -$29.4M | -$23M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $25M | $85M | |
| Long-Term Debt Repaid | -$335K | -$243K | -$392K | -$26.8M | -$31.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$1.5M | -- | -$1.1M | -$62M | |
| Cash From Financing | -$25.6M | -$21M | -$26.1M | -$32.6M | -$31.1M | |
| Beginning Cash (CF) | $39.7M | $44.3M | $25.8M | $17.5M | $38.3M | |
| Foreign Exchange Rate Adjustment | $19K | -$178K | $1.6M | $310K | -$1.9M | |
| Additions / Reductions | -$25.7M | -$28.9M | -$923K | -$1.8M | -$3M | |
| Ending Cash (CF) | $14.1M | $15.3M | $26.5M | $16.1M | $33.4M | |
| Levered Free Cash Flow | -$5.4M | $27.3M | -$6.6M | $32.6M | $23.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $62.5M | $126.4M | $93.3M | $119.1M | -- | |
| Depreciation & Amoritzation | $7.7M | $12M | $22M | $28.4M | -- | |
| Stock-Based Compensation | -- | $964K | $791K | $1.7M | $18.6M | |
| Change in Accounts Receivable | -$14.7M | -$62.7M | -$55.3M | $7.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $68.9M | $99.3M | $84.1M | $169.4M | -- | |
| Capital Expenditures | $824K | $3M | $5.9M | $16.3M | $6.5M | |
| Cash Acquisitions | -- | -$130.6M | -$34.8M | -$67.3M | -$52.4M | |
| Cash From Investing | -$294.3M | -$217.7M | $62.7M | -$11.8M | -- | |
| Dividends Paid (Ex Special Dividend) | -$87.7M | -$120.1M | -$125.1M | -$159.7M | -$72.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $110M | -- | |
| Long-Term Debt Repaid | -$854K | -$1M | -$1.5M | -$29.3M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$6.1M | -$1.3M | -$14.5M | -- | |
| Cash From Financing | $211.6M | $101.7M | -$129.7M | -$159.9M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$13.8M | -$16.8M | $17M | -$2.3M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $68M | $96.3M | $78.2M | $153.1M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $121.2M | $94.1M | $120.8M | $75.7M | -- | |
| Depreciation & Amoritzation | $8.8M | $21.2M | $27.1M | $35.8M | -- | |
| Stock-Based Compensation | $764K | $731K | $1.5M | $19.1M | -- | |
| Change in Accounts Receivable | -$65.3M | -$25.5M | -$10.7M | -$92.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $107.6M | $81.1M | $156.7M | $145.9M | -- | |
| Capital Expenditures | $1.8M | $6.7M | $15M | $8.3M | -- | |
| Cash Acquisitions | -$122.8M | -$42.5M | -$7.2M | -$112.6M | -- | |
| Cash From Investing | -$284.2M | -$189.3M | $62.2M | $25.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -$119.8M | -$103.3M | -$145.1M | -$132.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $25M | $261M | -- | |
| Long-Term Debt Repaid | -$832K | -$1.7M | -$28.4M | -$48.4M | -- | |
| Repurchase of Common Stock | -- | -- | -$65.2M | -$141.3M | -- | |
| Other Financing Activities | -$3.2M | -$4.7M | -$14.7M | -$89.2M | -- | |
| Cash From Financing | $177.9M | $118.5M | -$229.6M | -$151.7M | -- | |
| Beginning Cash (CF) | $112.3M | $70.4M | $97.2M | $110.3M | -- | |
| Foreign Exchange Rate Adjustment | -$12K | $1M | $267K | -$2.2M | -- | |
| Additions / Reductions | $1.2M | $10.3M | -$10.7M | $19.6M | -- | |
| Ending Cash (CF) | $113.5M | $81.7M | $86.7M | $127.7M | -- | |
| Levered Free Cash Flow | $105.7M | $74.3M | $141.7M | $137.7M | -- | |
Get PAX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PAX
Sector
P/E ratio
29.95x
12.21x
PEG ratio
0.66x
0.40x
P/B ratio
3.99x
1.11x
Price / LTM sales
5.56x
2.66x
Growth Metrics
PAX
Sector
Revenue growth
24.92%
5.12%
Earnings growth
-15.79%
2.63%
Revenue (5-year growth)
24.82%
5.17%
Earnings forecast
$0.30
$0.61
Profitability
PAX
Sector
Profitability FY 2024
$323.7M
$138.7M
Return on invested capital
10.41%
5.21%
Return on assets
5.77%
0.97%
Return on equity
13.9%
9.24%
Earnings Date
Last Earnings Date
May
2
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Aug
1
Balance Sheet
PAX
Sector
Total cash
$175.4M
$451.2M
Short term investments
$5M
$220.9M
Total assets
$1.2B
$3.8B
Long term debt
$192.1M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
